These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 30341513)
1. Predictive Value of BRAF Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513 [TBL] [Abstract][Full Text] [Related]
2. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer. Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400 [TBL] [Abstract][Full Text] [Related]
3. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma. Zhang Q; Liu SZ; Zhang Q; Guan YX; Chen QJ; Zhu QY Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894 [TBL] [Abstract][Full Text] [Related]
4. The synergic effect of BRAF Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763 [TBL] [Abstract][Full Text] [Related]
5. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Kim TH; Park YJ; Lim JA; Ahn HY; Lee EK; Lee YJ; Kim KW; Hahn SK; Youn YK; Kim KH; Cho BY; Park DJ Cancer; 2012 Apr; 118(7):1764-73. PubMed ID: 21882184 [TBL] [Abstract][Full Text] [Related]
6. BRAF Shi C; Cao J; Shi T; Liang M; Ding C; Lv Y; Zhang W; Li C; Gao W; Wu G; Man J World J Surg Oncol; 2020 Jun; 18(1):145. PubMed ID: 32593310 [TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation. Han Y; Hou L; Zhao B; Gao L; Li S Front Endocrinol (Lausanne); 2022; 13():884428. PubMed ID: 35784548 [TBL] [Abstract][Full Text] [Related]
10. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011 [TBL] [Abstract][Full Text] [Related]
11. Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Nam JK; Jung CK; Song BJ; Lim DJ; Chae BJ; Lee NS; Park WC; Kim JS; Jung SS; Bae JS Am J Surg; 2012 Apr; 203(4):436-41. PubMed ID: 21803329 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study. Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112 [TBL] [Abstract][Full Text] [Related]
13. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma. Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700 [TBL] [Abstract][Full Text] [Related]
14. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS Surgery; 2015 Dec; 158(6):1500-11. PubMed ID: 26120069 [TBL] [Abstract][Full Text] [Related]
16. Risk and Prognostic Factors for BRAF Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194 [TBL] [Abstract][Full Text] [Related]
17. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China. Huang M; Yan C; Xiao J; Wang T; Ling R Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059 [TBL] [Abstract][Full Text] [Related]
18. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785 [TBL] [Abstract][Full Text] [Related]
19. Predicting factors of central lymph node metastasis and BRAF Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769 [TBL] [Abstract][Full Text] [Related]
20. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma. Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]